ArticleFrontiers in immunology2025

Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report.

Takuto Nosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.